ℹ️ Compiled from public regulatory records · Last regulator revision: November 6, 2025
Ginsenoside
Active ingredient
Sold as QWG-1000
US FDA
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Topical
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 1
Overview
Plain-language summary, compiled from the cited regulatory records
Ginsenoside is an active ingredient used on muscles and veins as needed [1]. It is available under the brand name QWG-1000 [1].
In the past 12 months, there has been 1 adverse event report associated with Ginsenoside [2]. The top reaction reported was Swollen Tongue [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | November 6, 2025 |
USUnited States· FDA
1 product
Uses
Use on muscles and veins as needed
How to take
Sources & citations
- [1]FDA DailyMed · 09b1b1fc-285c-45… · revised November 6, 2025 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.